Treosulfan-based conditioning for inborn errors of immunity.

Ther Adv Hematol · 2021 · PMC8141989 · PMID 34094045

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A comparison with the published dosing scheme showed a trend for reduced over-exposure using the BSA dosing in the younger age groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.